An interaction between human Sec63 and nucleoredoxin may provide the missing link between the SEC63 gene and polycystic liver disease (Q24337764)

Molecular advances in autosomal dominant polycystic kidney disease

GOA release 2020-03-11

polycystic liver disease

1 reference

Linda Müller

1

0 references

Yosuke Funato

series ordinal

2

0 references

Hiroaki Miki

series ordinal

3

0 references

Richard Zimmermann

series ordinal

4

0 references

language of work or name

English

0 references

publication date

18 February 2011

0 references

published in

FEBS Letters

0 references

volume

585

0 references

issue

4

0 references

page(s)

596-600

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Polycystin-2 is an intracellular calcium release channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Polycystin-2 is regulated by endoplasmic reticulum-associated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion channel regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

TRPP2 channels regulate apoptosis through the Ca2+ concentration in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Polycystic liver disease is a disorder of cotranslational protein processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Mutations in SEC63 cause autosomal dominant polycystic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Disrupted cell adhesion but not proliferation mediates cyst formation in polycystic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Homologs of the yeast Sec complex subunits Sec62p and Sec63p are abundant proteins in dog pancreas microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Evolutionary gain of function for the ER membrane protein Sec62 from yeast to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Nucleoredoxin sustains Wnt/β-catenin signaling by retaining a pool of inactive dishevelled protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Convergence of Wnt, beta-catenin, and cadherin pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Crystal structure of the bb' domains of the protein disulfide isomerase ERp57

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulfide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Common design principles in the spliceosomal RNA helicase Brr2 and in the Hel308 DNA helicase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Structural evidence for consecutive Hel308-like modules in the spliceosomal ATPase Brr2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

7 January 2021

Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

7 January 2021

SnapShot: Wnt/beta-catenin signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

7 January 2021

Protein transport into the endoplasmic reticulum: mechanisms and pathologies

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

7 January 2021

Somatic inactivation of Pkd2 results in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

7 January 2021

HNPCC-associated small bowel cancer: clinical and molecular characteristics

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.01.024

7 January 2021